12 unchanged sentences
Other Information
−Removed: During the three months ended December 31, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
+Added: During the three months ended December 31, 2025, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as described in the table below:
+Added: Action Date Trading Arrangement Total Shares to be Purchased or Sold Duration/Expiration Date
+Added: Rule 10b5-1* Non-Rule 10b5-1**
+Added: Geiger , President
+Added: Adopt October 27, 2025 [1]
+Added: X Up to 23,028 shares to be sold
+Added: October 31, 2025
+Added: Burwig , Executive Vice President, Operations
+Added: Adopt October 27, 2025 [2]
+Added: X Up to 20,000 shares to be sold
+Added: Geiger , President
+Added: Adopt November 11, 2025
+Added: X Up to 11,000 shares to be sold
+Added: December 31, 2026
+Added: Troendle , Chief Executive Officer and Chairman of the Board
+Added: Adopt November 12, 2025 [3]
+Added: X Up to 150,000 shares to be sold
+Added: Good until cancelled or until the commencement of the next blackout period, whichever occurs first
+Added: Brady , Chief Financial Officer and Treasurer
+Added: Adopt November 21, 2025 [4]
+Added: X Up to 3,000 shares to be sold
+Added: The earlier of until cancelled or 180 days from the placement of the limit order
+Added: Burwig , Executive Vice President, Operations
+Added: Adopt November 24, 2025 [5]
+Added: X Up to 20,000 shares to be sold
+Added: Troendle , Chief Executive Officer and Chairman of the Board
+Added: Adopt November 24, 2025 [6]
+Added: X Up to 150,000 shares to be sold
+Added: Good until cancelled or until the commencement of the next blackout period, whichever occurs first
+Added: Troendle , Chief Executive Officer and Chairman of the Board
+Added: Terminate December 4, 2025 [7]
+Added: X Up to 150,000 shares to be sold
+Added: Good until cancelled or until the commencement of the next blackout period, whichever occurs first
+Added: * Intended to satisfy the affirmative defense of Rule 10b5-1(c).
+Added: ** Not intended to satisfy the affirmative defense of Rule 10b5-1(c).
+Added: [1] On October 27, 2025 , Mr.
+Added: Geiger placed a limit order to sell up to 23,028 shares issued to him pursuant to his contemporaneous exercise of stock options.
+Added: On October 27, 2025, Mr.
+Added: Geiger sold 19,460 shares pursuant to the limit order.
+Added: Geiger modified the limit price on October 28, 2025.
+Added: On October 29, 2025, Mr.
+Added: Geiger sold 3,568 shares pursuant to the limit order.
+Added: [2] On October 27, 2025 , Ms.
+Added: Burwig placed a limit order to sell up to 20,000 shares that were previously acquired through a stock option exercise.
+Added: [3] On November 12, 2025 , Mr.
+Added: Troendle placed a limit order to sell up to 150,000 shares.
+Added: Troendle modified the limit price on November 14, 2025.
+Added: [4] On November 21, 2025 , Mr.
+Added: Brady placed a limit order to sell up to 3,000 shares issued to him pursuant to his contemporaneous exercise of stock options.
+Added: [5] On November 24, 2025 , Ms.
+Added: Burwig placed a limit order to sell up to 20,000 shares that were previously acquired through a stock option exercise.
+Added: [6] On November 24, 2025 , Mr.
+Added: Troendle placed a limit order to sell up to 150,000 shares.
+Added: [7] On December 4, 2025 , Mr.
+Added: Troendle terminated the limit order originally adopted on November 24, 2025.
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
50 unchanged sentences
#10.1 Medpace Holdings, Inc.
−Removed: 2016 Incentive Award Plan
−Removed: 10-Q 001-37856 10.1 11/3/16
+Added: 2016 Amended and Restated Incentive Award Plan
+Added: 8-K 001-37856 10.1 5/16/25
#10.2 Medpace Holdings, Inc.
23 unchanged sentences
Non-Employee Director Compensation Policy revised October 21, 20 25
−Removed: 10-K 001-37856 10.10 2/14/23
10.11 Loan Agreement dated as of September 30, 2019, by and among Medpace, Inc., as borrower, and PNC Bank, National Association.
23 unchanged sentences
8-K 001-37856 10.1 3/29/24
+Added: 10.19 Amendment No.
+Added: 7 dated March 28, 2025 to Loan Documents
+Added: 8-K 001-37856 10.1 3/31/25
+Added: 10.20 Amendment No.
+Added: 8 dated April 18, 2025 to Loan Documents
+Added: 8-K 001-37856 10.1 4/21/25
+Added: 10.21 Amendment No.
+Added: 9 dated July 17, 2025 to Loan Documents
+Added: 8-K 001-37856 10.1 7/21/25
19.1 Insider Trading Compliance Policy
14 unchanged sentences
101.PRE Inline XBRL Taxonomy Extension Presentation *
+Added: Incorporated by Reference
+Added: Number Exhibit Description Form File No.
+Added: Exhibit Filing
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
34 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.